Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02768363
Recruitment Status : Active, not recruiting
First Posted : May 11, 2016
Last Update Posted : October 11, 2019
Sponsor:
Information provided by (Responsible Party):
Advantagene, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2020
Study Completion Date : No date given